Artivion rises as Jefferies initiates at buy, sees ’attractive entry point’

Investing.com -- Artivion Inc (NYSE:AORT) shares gained 4.2% Tuesday after Jefferies initiated coverage on the cardiovascular medical device maker with a Buy rating and a $31 price target, framing the company as a compelling play on aortic surgery growth. The bullish call reflects optimism surrounding Artivion’s expanding product pipeline, which Wall Street expects to drive double-digit revenue expansion alongside expanding profit margins.